Savara (SVRA) Prepaid Assets (2010 - 2026)

Savara (SVRA) reported Prepaid Assets of $6.5 million for Q1 2026, up 4347.26% year-over-year from $146000.0 in Q1 2025, and up 9.79% on a QoQ basis from $5.9 million in Q4 2025.

Savara (SVRA) has 17 years of Prepaid Assets data on file, last reported at $6.5 million in Q1 2026.

  • Quarterly Prepaid Assets rose 4347.26% year-over-year to $6.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 million (up 4347.26% YoY) and the FY2025 annual result came in at $5.9 million, up 4414.5% from the prior year.
  • Prepaid Assets climbed to $6.5 million in Q1 2026 per SVRA's latest filing, from $5.9 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $7.0 million in Q3 2024 and bottomed at $131000.0 in Q4 2024.
  • The 5-year median for Prepaid Assets is $231000.0 (2022), against an average of $2.2 million.
  • Peak annual rise in Prepaid Assets reached 4414.5% in 2025, while the deepest fall reached 96.81% in 2025.
  • Tracing SVRA's Prepaid Assets over 5 years: stood at $231000.0 in 2022, then retreated by 23.81% to $176000.0 in 2023, then decreased by 25.57% to $131000.0 in 2024, then surged by 4414.5% to $5.9 million in 2025, then advanced by 9.79% to $6.5 million in 2026.
  • Per Business Quant, the three latest SVRA Prepaid Assets figures stand at $6.5 million (Q1 2026), $5.9 million (Q4 2025), and $3.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Savara 1.30 Bn 1.30 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.49 Mn
Dec 31, 2025 5.91 Mn
Sep 30, 2025 3.81 Mn
Jun 30, 2025 197,000.00
Mar 31, 2025 146,000.00
Dec 31, 2024 131,000.00
Sep 30, 2024 6.96 Mn
Jun 30, 2024 6.18 Mn
Mar 31, 2024 133,000.00
Dec 31, 2023 176,000.00
Sep 30, 2023 201,000.00
Jun 30, 2023 2.72 Mn
Mar 31, 2023 137,000.00
Dec 31, 2022 231,000.00
Sep 30, 2022 240,000.00
Jun 30, 2022 2.95 Mn
Mar 31, 2022 187,000.00
Dec 31, 2021 3.83 Mn
Sep 30, 2021 369,000.00
Jun 30, 2021 2.82 Mn
Mar 31, 2021 2.09 Mn
Dec 31, 2020 453,000.00
Sep 30, 2020 1.99 Mn
Jun 30, 2020 2.95 Mn
Mar 31, 2020 2.46 Mn
Dec 31, 2019 2.31 Mn
Sep 30, 2019 74,000.00
Jun 30, 2019 261,000.00
Mar 31, 2019 121,000.00
Dec 31, 2018 2.51 Mn
Sep 30, 2018 289,000.00
Jun 30, 2018 430,000.00
Mar 31, 2018 123,000.00
Dec 31, 2017 158,000.00
Sep 30, 2017 263,000.00
Jun 30, 2017 368,000.00
Mar 31, 2017 388,000.00
Dec 31, 2016 840,000.00
Sep 30, 2016 1.33 Mn
Jun 30, 2016 746,000.00
Mar 31, 2016 1.16 Mn
Dec 31, 2015 1.27 Mn
Sep 30, 2015 1.54 Mn
Jun 30, 2015 1.37 Mn
Mar 31, 2015 675,000.00
Dec 31, 2014 1.11 Mn
Sep 30, 2014 984,841.00
Jun 30, 2014 1.13 Mn
Mar 31, 2014 992,474.00
Dec 31, 2013 1.14 Mn
Sep 30, 2013 542,423.00
Jun 30, 2013 684,126.00
Mar 31, 2013 511,216.00
Dec 31, 2012 662,260.00
Sep 30, 2012 700,650.00
Jun 30, 2012 484,469.00
Mar 31, 2012 292,691.00
Dec 31, 2011 256,311.00
Sep 30, 2011 560,802.00
Jun 30, 2011 776,178.00
Dec 31, 2010 428,276.00